We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patien... ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. Show more
Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital Lowers ADMA’s Total Debt to $75 Million, a 29% Reduction Further Supports Earnings Growth Outlook...
3Q 2024 Total Revenue of $119.8 Million, a 78% Increase Y-o-Y 3Q 2024 GAAP Net Income of $35.9 Million, a 1,300% Increase Y-o-Y 3Q 2024 Adjusted EBITDA(1) of $45.4 Million, a 256% Increase Y-o-Y ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.3212 | 1.87179487179 | 17.16 | 17.96 | 17.08 | 2897134 | 17.53035544 | CS |
4 | -4.2588 | -19.5896964121 | 21.74 | 21.78 | 17.08 | 2669834 | 18.83799666 | CS |
12 | -2.4088 | -12.1106083459 | 19.89 | 23.64 | 15.33 | 3689264 | 18.76667937 | CS |
26 | 6.6412 | 61.2656826568 | 10.84 | 23.64 | 10.21 | 4202233 | 17.54031699 | CS |
52 | 13.1212 | 300.944954128 | 4.36 | 23.64 | 4.36 | 3501312 | 13.38639487 | CS |
156 | 16.2112 | 1276.47244094 | 1.27 | 23.64 | 1.17 | 2814321 | 7.25899924 | CS |
260 | 13.4412 | 332.702970297 | 4.04 | 23.64 | 1.01 | 3184537 | 4.91021692 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions